Browse open grants
757 matching grants, sorted by deadline.
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) | National Institutes of Health | July 5, 2029 | — | Nonprofits |
| NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) | National Institutes of Health | July 5, 2029 | $500k | Nonprofits |
| Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed) | National Institutes of Health | July 5, 2029 | $500k | Nonprofits |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | National Institutes of Health | July 5, 2029 | $500k | Nonprofits |
| Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) | National Institutes of Health | July 12, 2029 | — | Nonprofits |
| Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) | National Institutes of Health | July 12, 2029 | — | Nonprofits |
| Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed) | National Institutes of Health | July 16, 2029 | — | Nonprofits |
| RFA-DD-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-GH-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-TS-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-SH-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-PS-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-IP-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-CK-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-DP-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-CE-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-EH-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-TP-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-CC-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-CD-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-OT-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| RFA-OE-18-000 | Centers for Disease Control and Prevention - ERA | September 30, 2030 | $0 | |
| State Veterans Home Construction Grant Program | Construction of State Home Facilities | Rolling / TBD | $275M | |
| Bridges to the Doctorate Program (R25) | National Institutes of Health | Rolling / TBD | — | |
| Assay Development for High Throughput Molecular Screening (R21) | National Institutes of Health | Rolling / TBD | — | Nonprofits |
| Support for Locally-led Development Approaches Annual Program Statement | Sudan USAID-Khartoum | Rolling / TBD | $30M | Nonprofits Individuals |
| Support of NIGMS Program Project Grants (P01) | National Institutes of Health | Rolling / TBD | — | Nonprofits |
| Disability Funding | West Bank, Gaza USAID-West Bank | Rolling / TBD | $600k | |
| Grants for Alzheimer's Disease Drug Discovery (R21) | National Institutes of Health | Rolling / TBD | $200k | Nonprofits |
| Drug Abuse, Risky Decision Making and HIV/AIDS (R03) | National Institutes of Health | Rolling / TBD | — | Nonprofits |
| Drug Abuse, Risky Decision Making and HIV/AIDS (R01) | National Institutes of Health | Rolling / TBD | — | Nonprofits |
| Drug Abuse, Risky Decision Making and HIV/AIDS (R21) | National Institutes of Health | Rolling / TBD | $200k | Nonprofits |
| NIGMS Postbaccalaureate Research Education Program (PREP) [R25] | National Institutes of Health | Rolling / TBD | — | |
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) - NIDA (R03) | National Institutes of Health | Rolling / TBD | — | Nonprofits |
| Dental School Joint DDS or DMD/Masters Degree NRSA Research Training Program (T32) | National Institutes of Health | Rolling / TBD | $250k | |
| Neuroimaging Informatics Software Enhancement for Improved Interoperability and Dissemination (R03) | National Institutes of Health | Rolling / TBD | — | Nonprofits |
| Rapid Strengthening and Expansion of Integrated Social Services for People Living with HIV/AIDS (PLWHA) in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief | Centers for Disease Control and Prevention | Rolling / TBD | $100k | |
| Global Research Initiative Program, Behavioral/Social Sciences (R01) | National Institutes of Health | Rolling / TBD | $50k | |
| Vector Borne Disease Prevention Program for Yosemite National Park | National Park Service | Rolling / TBD | $140k | Nonprofits |
| National Accessibility Technical Assistance and Support | National Park Service | Rolling / TBD | $100k | |
| Vector-Borne Disease Prevention Program for Yosemite National Park | National Park Service | Rolling / TBD | $0 | Nonprofits |
| Partnership for Surveillance Collaborative | Centers for Disease Control and Prevention | Rolling / TBD | $0 | |
| Cougar Ridge Habitat Restoration | Fish and Wildlife Service | Rolling / TBD | $0 | Individuals |
| NIH Small Research Grant Program (Parent R03) | National Institutes of Health | Rolling / TBD | $50k | Nonprofits |
| NIH Exploratory/Developmental Research Grant Program (Parent R21) | National Institutes of Health | Rolling / TBD | $200k | Nonprofits |
| Secondary Analyses in Obesity, Diabetes, Digestive and Kidney Diseases (R21) | National Institutes of Health | Rolling / TBD | $200k | Nonprofits |
| Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) | National Institutes of Health | Rolling / TBD | $50k | Nonprofits |
| Pilot Studies: Oral Complications of Cancer Therapies (R21) | National Institutes of Health | Rolling / TBD | $200k | Nonprofits |
| Clinical Trials: Oral Complications of Cancer Therapy (R21) | National Institutes of Health | Rolling / TBD | $200k | Nonprofits |
| Cutting-Edge Basic Research Awards (CEBRA) (R21) | National Institutes of Health | Rolling / TBD | $100k | Nonprofits |